Arizona Sun Sunscreen Spf15 Lotion
NDC Package 61973-101-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Arizona Sun Sunscreen Spf15 (sunscreen) lotions is apply liberally and evenly to the skin 30 minutes before and during sun exposure. This formulation utilizes a lotion delivery system. Marketed by Arizona Sun, this product is identified by NDC 61973-101 and is authorized under FDA application M020.

Identification & Billing

NDC Package Code
61973-101-01
Package Description
30 g in 1 BOTTLE
Product Code
61973-101
11-Digit Billing Format
61973010101

Clinical Specifications

Proprietary Name
Arizona Sun Sunscreen Spf15
Non-Proprietary Name
Sunscreen
Substance Name
Avobenzone; Octinoxate; Octisalate; Oxybenzone
Dosage Form
Lotion - An emulsion, liquid1 dosage form. This dosage form is generally for external application to the skin.2
Administration Route
  • Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
  • Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
  • Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
  • Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Usage Information
Apply liberally and evenly to the skin 30 minutes before and during sun exposure. Reapply as needed or after towel drying, perspiring, swimming, and vigorous activities.

Regulatory & Marketing

Labeler Name
Arizona Sun
Product Type
Human Otc Drug
FDA Application #
M020
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
02-05-2024
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (61973-101). Click a package code to view its specific billing and regulatory data.

61973-101-03
90 g in 1 BOTTLE
61973-101-04
120 g in 1 BOTTLE
61973-101-08
946 g in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 61973-101-01 identifies a specific commercial package of 30 g in 1 bottle of Arizona Sun Sunscreen Spf15, a human over the counter drug labeled by Arizona Sun. This lotion is formulated for topical use and contains avobenzone; octinoxate; octisalate; oxybenzone as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Arizona Sun on February 05, 2024. The current certification is valid through December 31, 2027.

How is this Arizona Sun product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 61973010101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
61973-101-01
11-Digit CMS (5-4-2)
61973-0101-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.